课题基金 / 基金详情

New hemoglobin derivative aimed for improvement of oxygen metabolism in severe sepsis

New hemoglobin derivative aimed for improvement of oxygen metabolism in severe sepsis
新的血红蛋白衍生物旨在改善严重脓毒症的氧代谢
批准号:
14370347
负责人:
SHINOZAWA Yotaro
金额:
$4.42万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2003

项目摘要

项目成果

SHINOZAWA Yotaro的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We have made S-Nitrosylated Polyethylene Glycol-conjugated Hemoglobin Derivative (SNO-Hb) which can donate nitric oxide (NO) as well as deliver the oxygen and have found this derivative is useful for the treatment of hemorrhagic shock in rat model. In this study, we are going to make new hemoglobin derivatiye useful in sepsis where plenty of NO exists and impaires oxygen uptake in the peripheral tissue.Cecum ligation puncture (CLP, ligated coecum was puctured twice by 18G needle) was performed in 250〜300g weighed Spraugue-Dowley rats3, making sepsis model (peritonitis). In control rats (n=7),anesthesia only (n=5),laparotomy only (n=5),and CLP (n=6),body temparature was 37.4±0.2℃,36.3±0.5,36.7±0.8,33.6±1.1,respectively, Also, blood pressure was 128±4 mmHg,120±4,129±7,105±6,respectively, heart rate was 515±7/min,466±14, 508±25,400±35,respectively, and CO2 production (1-2 hours post each procesure) was 2.25±0.15g/BWkg/hour, 2.06±00.12,2.06±0.10,1.43±0.18,respectiveiy. In CLP rats, metabolic rate was decreased and not in hyperdymanic circulatory state but in hypodymanic state.We could successfully measured stable metabolic rate in septic rats by the modified metabolic cage for CO2 production.We are going to make hyperdymanic circulatory state rat model by changing the size of puncture hole smaller in the ligated coecum.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
小池薫, 他: "敗血症モデル"日本外科学会雑誌. 104・11. 800-804 (2003)
小池薰等人:《脓毒症模型》日本外科学会杂志 104・11(2003 年)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nakai K., et al.: "S-nitrosylated polyethylene glycol-conjugated hemoglobin derivative as a candidate material for oxygen therapeutics"Advances Experimental Medicine and Biology. 519. 207-216 (2003)
Nakai K.等人:“S-亚硝基化聚乙二醇结合的血红蛋白衍生物作为氧疗法的候选材料”促进了实验医学和生物学的发展。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nakai K., et al.: "S-nitrosylated polyethylene glycol-conjugated hemoglobin derivative as a candidate material for oxygen therapeutics."Advances Experimental Medicine and Biology. 519. 207-216 (2003)
Nakai K.等人:“S-亚硝基化聚乙二醇结合的血红蛋白衍生物作为氧疗法的候选材料。”推进实验医学和生物学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
篠澤洋太郎: "アルギニンの効果と副作用"JJPEN. 24. 691-698 (2002)
筱泽阳太郎:“精氨酸的作用和副作用” JJPEN 24. 691-698 (2002)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
8
    High quality cardiopulmonary-brain resuscitation with antioxidant administration just before starting resuscitation (Animal study)
    Microcircutation in burned wound and usefulness of microcirculation modulation
    • 批准号:
      08671383
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.41万
    • 财政年份:
      1996
    • 负责人:
      SHINOZAWA Yotaro
    • 依托单位:
    Pathophysiological analysis of third degree burn and efficacy of total escharectomy in super early phase of burn injury
    • 批准号:
      04670750
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.41万
    • 财政年份:
      1992
    • 负责人:
      SHINOZAWA Yotaro
    • 依托单位:
    国内基金
    海外基金
    脓毒症血浆胞外囊泡(Sepsis-EVs)通过S100A8/A9-RAGE-EEA1通路诱导急性肺损伤的机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      夏杰
    • 依托单位:
    miR-802靶向SDC4炎症反应信号通路调控sepsis相关性ALI的作用和机制
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      朱志鹏
    • 依托单位:
    精氨酸调控骨髓Tregs稳态在脓毒症骨髓功能障碍中的作用研究
    • 批准号:
      82371770
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      宁铂涛
    • 依托单位:
    RIPK3蛋白及其RHIM结构域在脓毒症早期炎症反应和脏器损伤中的作用和机制研究
    • 批准号:
      82372167
    • 项目类别:
      面上项目
    • 资助金额:
      48.00万元
    • 批准年份:
      2023
    • 负责人:
      江继宏
    • 依托单位: